# US 2013/0253022 A1 · Novel fluorinated sulfamides exhibiting neuroprotective action and their method of use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0253022 A1
- Document ID: US20130253022A1
- Status: Published application
- Kind: A1
- Application number: 13/990,630
- Filed: 2011-11-18
- Published: 2013-09-26
- Earliest claimed: 2010-11-30
- Assignees: Fox Chase Chemical Diversity Center, Inc.; Advanced Neural Dynamics, Inc.
- Inventors: Garry Robert Smith; Douglas E. Brenneman; Allen B. Reitz; Yan Zhang; Yanming Du
- Web page: https://patentgrep.com/patent/US20130253022A1

## CPC

- C07C 307/06: having nitrogen atoms of the sulfamide groups bound to acyclic carbon atoms
- C07D 261/20: condensed with carbocyclic rings or ring systems
- C07D 263/56: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D 333/58: Radicals substituted by nitrogen atoms
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

Pharmaceutical compositions of the invention include fluorinated sulfamide derivatives having a disease-modifying action in the treatment of diseases associated with excitotoxicity and accompanying oxidative stress that include epilepsy, Alzheimer's disease, Parkinson's disease, Huntington's disease, heavy metal toxicity and any neurodegenerative disease involving glutamate toxicity.

## Claims

### Claim 1

A compound of formula (I):
wherein:
R is selected from the group consisting of optionally substituted aryl, optionally substituted benzoisoxazole, and optionally substituted benzothiophene where R may be substituted by 0-5 moieties; and
R1 is selected from the group consisting of hydrogen, fluorine, and optionally substituted C1-6 alkyl; or a pharmaceutically acceptable salt form thereof.

### Claim 2 (depends on 1)

The compound according to claim 1 wherein R is phenyl, 2-fluorophenyl, 3-fluorophenyl, 4-fluorophenyl, 2,4-difluorophenyl, 2,5-difluorophenyl, 2,6-difluorophenyl, 2-chlorophenyl, 2-bromophenyl, 2-trifluoromethylphenyl, 3-trifluoromethylphenyl, 2,6-dichlorophenyl, 2,4-dichlorophenyl, 2-methylphenyl, 2-ethylphenyl, 2-methoxyphenyl, 2-chloro-6-fluorophenyl, 2-chloro-4-fluorophenyl, 2-fluoro-6-methoxyphenyl, 4-fluoro-2-methoxyphenyl, 2-chloro-6-methoxyphenyl, benzo[b]thiophen-3-yl, or benzo[d]isoxazol-3-yl.

### Claim 3 (depends on 1)

The compound according to claim 1 wherein R1 is methyl or hydrogen.

### Claim 4 (depends on 1)

The compound according to claim 1 wherein R1 is fluorine.

### Claim 5 (depends on 1)

The compound according to claim 1 that is:
2,2-Difluoro-2-phenyl-ethyl-1-sulfamide;
2,2-Difluoro-2-(2-fluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(3-fluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(4-fluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2,6-difluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2,4-difluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2,5-difluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-chlorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-trifluoromethylphenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(3-trifluoromethylphenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2,6-dichlorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2,4-dichlorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-methylphenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-methoxyphenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-chloro-6-fluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-chloro-4-fluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-fluoro-6-methoxyphenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(4-fluoro-2-methoxyphenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-chloro-6-methoxyphenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(benzo[b]thiophen-3-yl)ethyl-1-sulfamide;
2,2-Difluoro-2-(benzo[d]isoxazol-3-yl)ethyl-1-sulfamide;
2-Fluoro-2-methyl-(2-chlorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-phenyl-ethyl-1-sulfamide;
2-Fluoro-2-(2-fluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(3-fluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(4-fluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2,6-difluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2,4-difluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2,5-difluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-chlorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-trifluoromethylphenyl)ethyl-1-sulfamide;
2-Fluoro-2-(3-trifluoromethylphenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2,6-dichlorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2,4-dichlorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-methylphenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-methoxyphenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-chloro-6-fluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-chloro-4-fluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-fluoro-6-methoxyphenyl)ethyl-1-sulfamide;
2-Fluoro-2-(4-fluoro-2-methoxyphenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-chloro-6-methoxyphenyl)ethyl-1-sulfamide;
2-Fluoro-2-(benzo[b]thiophen-3-yl)ethyl-1-sulfamide;
2-Fluoro-2-(benzo[d]isoxazol-3-yl)ethyl-1-sulfamide;
2-Fluoro-2-methyl-(2-fluorophenyl)ethyl-1-sulfamide;
or a pharmaceutically acceptable form thereof.

### Claim 6 (depends on 1)

A composition comprising an effective amount of at least one compound according to claim 1.

### Claim 7 (depends on 6)

A composition according to claim 6, further comprising at least one excipient.

### Claim 8 (depends on 7)

A composition according to claim 7, wherein the at least one compound is at least one member selected from the group consisting of
2,2-Difluoro-2-phenyl-ethyl-1-sulfamide;
2,2-Difluoro-2-(2-fluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(3-fluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(4-fluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2,6-difluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2,4-difluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2,5-difluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-chlorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-trifluoromethylphenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(3-trifluoromethylphenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2,6-dichlorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2,4-dichlorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-methylphenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-methoxyphenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-chloro-6-fluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-chloro-4-fluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-fluoro-6-methoxyphenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(4-fluoro-2-methoxyphenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-chloro-6-methoxyphenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(benzo[b]thiophen-3-yl)ethyl-1-sulfamide;
2,2-Difluoro-2-(benzo[d]isoxazol-3-yl)ethyl-1-sulfamide;
2-Fluoro-2-methyl-(2-chlorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-phenyl-ethyl-1-sulfamide;
2-Fluoro-2-(2-fluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(3-fluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(4-fluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2,6-difluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2,4-difluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2,5-difluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-chlorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-trifluoromethylphenyl)ethyl-1-sulfamide;
2-Fluoro-2-(3-trifluoromethylphenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2,6-dichlorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2,4-dichlorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-methylphenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-methoxyphenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-chloro-6-fluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-chloro-4-fluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-fluoro-6-methoxyphenyl)ethyl-1-sulfamide;
2-Fluoro-2-(4-fluoro-2-methoxyphenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-chloro-6-methoxyphenyl)ethyl-1-sulfamide;
2-Fluoro-2-(benzo[b]thiophen-3-yl)ethyl-1-sulfamide;
2-Fluoro-2-(benzo[d]isoxazol-3-yl)ethyl-1-sulfamide;
2-Fluoro-2-methyl-(2-fluorophenyl)ethyl-1-sulfamide; and
pharmaceutically acceptable forms thereof.

### Claim 9 (depends on 1)

A method for treating a disease associated with excessive glutamate, said method comprising administering to a subject an effective amount of at least one compound according to claim 1 to treat the disease.

### Claim 10 (depends on 9)

The method of claim 9, wherein the at least one compound is administered in a composition further comprising at least one excipient.

### Claim 11 (depends on 10)

The method of claim 10, wherein the at least one compound is at least one member selected from the group consisting of
2,2-Difluoro-2-phenyl-ethyl-1-sulfamide;
2,2-Difluoro-2-(2-fluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(3-fluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(4-fluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2,6-difluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2,4-difluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2,5-difluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-chlorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-trifluoromethylphenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(3-trifluoromethylphenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2,6-dichlorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2,4-dichlorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-methylphenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-methoxyphenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-chloro-6-fluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-chloro-4-fluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-fluoro-6-methoxyphenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(4-fluoro-2-methoxyphenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-chloro-6-methoxyphenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(benzo[b]thiophen-3-yl)ethyl-1-sulfamide;
2,2-Difluoro-2-(benzo[d]isoxazol-3-yl)ethyl-1-sulfamide;
2-Fluoro-2-methyl-(2-chlorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-phenyl-ethyl-1-sulfamide;
2-Fluoro-2-(2-fluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(3-fluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(4-fluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2,6-difluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2,4-difluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2,5-difluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-chlorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-trifluoromethylphenyl)ethyl-1-sulfamide;
2-Fluoro-2-(3-trifluoromethylphenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2,6-dichlorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2,4-dichlorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-methylphenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-methoxyphenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-chloro-6-fluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-chloro-4-fluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-fluoro-6-methoxyphenyl)ethyl-1-sulfamide;
2-Fluoro-2-(4-fluoro-2-methoxyphenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-chloro-6-methoxyphenyl)ethyl-1-sulfamide;
2-Fluoro-2-(benzo[b]thiophen-3-yl)ethyl-1-sulfamide;
2-Fluoro-2-(benzo[d]isoxazol-3-yl)ethyl-1-sulfamide;
2-Fluoro-2-methyl-(2-fluorophenyl)ethyl-1-sulfamide;
and pharmaceutically acceptable forms thereof.

### Claim 12 (depends on 9)

The method of claim 9, wherein the disease is a neurodegenerative disease or epilepsy.

### Claim 13 (depends on 12)

The method of claim 12, wherein the neurodegenerative disease is Parkinson's disease, Huntington's disease or Alzheimer's disease.

### Claim 14 (depends on 10)

The method of claim 10, wherein the disease is a neurodegenerative disease or epilepsy.

### Claim 15 (depends on 14)

The method of claim 14, wherein the neurodegenerative disease is Parkinson's disease, Huntington's disease or Alzheimer's disease.

### Claim 16 (depends on 11)

The method of claim 11, wherein the disease is a neurodegenerative disease or epilepsy.

### Claim 17 (depends on 16)

The method of claim 16, wherein the neurodegenerative disease is Parkinson's disease, Huntington's disease or Alzheimer's disease.

### Claim 18 (depends on 1)

A method for treating a disease associated with reactive oxygen species, said method comprising administering to a subject an effective amount of at least one compound according to claim 1.

### Claim 19 (depends on 18)

The method of claim 18, wherein the at least one compound is administered in a composition further comprising at least one excipient.

### Claim 20 (depends on 18)

The method of claim 18, wherein the at least one compound is at least one member selected from the group consisting of
2,2-Difluoro-2-phenyl-ethyl-1-sulfamide;
2,2-Difluoro-2-(2-fluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(3-fluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(4-fluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2,6-difluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2,4-difluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2,5-difluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-chlorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-trifluoromethylphenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(3-trifluoromethylphenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2,6-dichlorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2,4-dichlorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-methylphenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-methoxyphenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-chloro-6-fluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-chloro-4-fluorophenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-fluoro-6-methoxyphenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(4-fluoro-2-methoxyphenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(2-chloro-6-methoxyphenyl)ethyl-1-sulfamide;
2,2-Difluoro-2-(benzo[b]thiophen-3-yl)ethyl-1-sulfamide;
2,2-Difluoro-2-(benzo[d]isoxazol-3-yl)ethyl-1-sulfamide;
2-Fluoro-2-methyl-(2-chlorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-phenyl-ethyl-1-sulfamide;
2-Fluoro-2-(2-fluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(3-fluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(4-fluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2,6-difluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2,4-difluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2,5-difluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-chlorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-trifluoromethylphenyl)ethyl-1-sulfamide;
2-Fluoro-2-(3-trifluoromethylphenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2,6-dichlorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2,4-dichlorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-methylphenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-methoxyphenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-chloro-6-fluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-chloro-4-fluorophenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-fluoro-6-methoxyphenyl)ethyl-1-sulfamide;
2-Fluoro-2-(4-fluoro-2-methoxyphenyl)ethyl-1-sulfamide;
2-Fluoro-2-(2-chloro-6-methoxyphenyl)ethyl-1-sulfamide;
2-Fluoro-2-(benzo[b]thiophen-3-yl)ethyl-1-sulfamide;
2-Fluoro-2-(benzo[d]isoxazol-3-yl)ethyl-1-sulfamide;
2-Fluoro-2-methyl-(2-fluorophenyl)ethyl-1-sulfamide;
and pharmaceutically acceptable forms thereof.

### Claim 21 (depends on 18)

The method of claim 18, wherein the disease is heavy metal toxicity.

### Claim 22 (depends on 18)

The method of claim 18, wherein the disease is iron, zinc, copper, cobalt, or nickel toxicity.

### Claim 23 (depends on 19)

The method of claim 19, wherein the disease is heavy metal toxicity.

### Claim 24 (depends on 19)

The method of claim 19, wherein the disease is iron, zinc, copper, cobalt, or nickel toxicity.

### Claim 25 (depends on 20)

The method of claim 20, wherein the disease is heavy metal toxicity.

### Claim 26 (depends on 20)

The method of claim 20, wherein the disease is iron, zinc, copper, cobalt, or nickel toxicity.

### Claim 27 (depends on 1)

A method for treating a disease associated with reactive oxygen species and heavy metal toxicity, said method comprising administering to a subject an effective amount of at least one compound according to claim 1.
